SureTrader
Home > Boards > US Listed > Biotechs > Inovio Pharmaceuticals, Inc. (INO)

Message Boards are for expressing a thought, a

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Inovioinvestor Member Profile
 
Followed By 0
Posts 119
Boards Moderated 0
Alias Born 03/14/13
160x600 placeholder
Inovio’s Co-Founder along with its Lead Antigen Designer Named Among Top 20 Researchers With Most Granted U.S Patents for ... "GlobeNewswire Inc." - 1/17/2018 8:00:00 AM
Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy Establish Clinical Development Collaboration To Eval... "GlobeNewswire Inc." - 1/9/2018 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/8/2018 8:17:32 AM
Inovio Receives Milestone Payment from MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squa... "GlobeNewswire Inc." - 1/8/2018 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/2/2018 4:07:26 PM
Inovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China "GlobeNewswire Inc." - 1/2/2018 8:00:00 AM
Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development "GlobeNewswire Inc." - 12/11/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/6/2017 2:08:10 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 12/6/2017 2:06:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/6/2017 1:58:14 PM
Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors "GlobeNewswire Inc." - 12/6/2017 8:00:00 AM
Inovio’s Further Analysis of VGX-3100 Phase 2b Data Reveals Immune Correlates and Biomarker Signatures That Predicted Clini... "GlobeNewswire Inc." - 11/29/2017 8:00:00 AM
Inovio Pharmaceuticals SynCon® TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor a... "GlobeNewswire Inc." - 11/27/2017 8:00:00 AM
Inovio Pharmaceuticals Presents Immuno-Oncology Advancements At Society for Immunotherapy of Cancer Conference "GlobeNewswire Inc." - 11/10/2017 10:27:55 AM
Inovio Pharmaceuticals to Participate In Upcoming Investment Conferences "GlobeNewswire Inc." - 11/9/2017 8:00:00 AM
Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results "GlobeNewswire Inc." - 11/8/2017 4:05:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/8/2017 3:58:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/2/2017 6:07:10 AM
Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical Study for Glioblastoma in Combination with Regeneron’s PD-1 Inhi... "GlobeNewswire Inc." - 11/1/2017 9:18:26 AM
Inovio Pharmaceuticals to Report Third Quarter 2017 Financial Results on November 8, 2017 "GlobeNewswire Inc." - 10/26/2017 8:00:00 AM
Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study... "GlobeNewswire Inc." - 10/24/2017 8:00:00 AM
Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inh... "GlobeNewswire Inc." - 10/16/2017 7:00:00 AM
Inovio’s Positive Zika Vaccine Clinical Study Data Published in New England Journal of Medicine "GlobeNewswire Inc." - 10/5/2017 7:00:00 AM
Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Prec... "GlobeNewswire Inc." - 9/21/2017 8:00:00 AM
Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS Infection "GlobeNewswire Inc." - 9/18/2017 8:00:00 AM
Inovioinvestor   Tuesday, 07/30/13 06:34:50 AM
Re: None
Post # of 14154 
Message Boards are for expressing a thought, a belief or simply to discuss an idea! Some will post informative educated posts, some will simply express how they feel about a stock, some will bash a positive investors post as much as a basher's post even though they are invested in INO! Lets not forget this is the internet which lets people write whatever they think appropriate whether informative, pumping, bashing or simply enthusiastic about the stock. There are people on this MB and many other MB's who's real intentions are well disguised! I see this almost everyday where one moment somebody is bashing the stock and the next pumping it! I have also lately seen a different type of basher appear as the INO SP has risen. These basher's try to bring up questions that have been answered too many times in the past, yet they like to dig up the past in some kind of way of reflection of where INO is today. The 30 year question for example! Anyone with half a brain cell would know that INO are NOT the same company of old! But the most dangerous poster in MHO is the one that states they "hate" the pumper's more than the basher's! These so called investor longs are mostly old time investors who feel they are losing control of this MB! They rarely if ever answer a basher's post but are very quick to jump down the necks of those who are genuinely excited or enthusiastic over a stock which will change the way that the world's doctors and scientists treats deadly viruses and disease in the not too distant future! My point here is: there are many people on this MB and other MB's with hidden agendas and as such, take everything posted with a pinch of salt! Continuity in a members posts, truthfulness, intelligent and honest posters without hidden agendas are hard to find! Read as much as you can, research yourself and make an informed choice before you listen to anyone on a MB! As for the "longs" who hate positive enthusiastic posters, you seriously need to remember where your invested because the positive on this or any other MB are protecting your investment whether you like it or not! Basher's DO NOT!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist